Jeff Yass’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History
Bought
Maintained
Sold
Other funds holding BIS
Jeff Yass's BIS Position: Q3 2026 in Review
Jeff Yass increased its ProShares UltraShort NASDAQ Biotechnology (BIS) stake by 25% in Q3 2026, buying an estimated $138K and bringing the position to 55,615 shares worth $621K. The position accounts for ﹤0.01% of the portfolio, ranked #9151.
Jeff Yass first reported a position in BIS in Q2 2013 and has held it in 37 quarters since. The position peaked at $3.63M in Q3 2015. 3 funds tracked by Wall St. Rank hold BIS as of Q3 2026.
- Jeff Yass held 55,615 shares of ProShares UltraShort NASDAQ Biotechnology worth $621K as of Q3 2026.
- Jeff Yass bought 11,256 ProShares UltraShort NASDAQ Biotechnology shares in Q3 2026, an estimated $138K.
- ProShares UltraShort NASDAQ Biotechnology made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #9151 holding.
- Jeff Yass first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q2 2013 and has held it in 37 quarters since.
- Jeff Yass's ProShares UltraShort NASDAQ Biotechnology position peaked at $3.63M in Q3 2015.
- 3 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.